跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LENALIDOMIDA OLPHA 25 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LENALIDOMIDA OLPHA 25 MG CAPSULAS DURAS EFG
Approved
STANDARD
LENALIDOMIDA OLPHA 25 MG CAPSULAS DURAS EFG
Olpha As
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 26, 2021
Approval ID
4a7ab6050bd13bbe
Company
Olpha As
Type
Standard
Approval Details
Approval Id
4a7ab6050bd13bbe
Drug Cima Aemps Name
LENALIDOMIDA OLPHA 25 MG CAPSULAS DURAS EFG
Register Number
86360
Holder Company Name
Olpha As
Marketing Company Name
Olpha As
Holder Company Detail Path
/organization/olainfarm-predstavitelstvo
Marketing Company Detail Path
/organization/olainfarm-predstavitelstvo
Authorization Date
2021-10-26
Dosage Form
CÁPSULA DURA
Dose
25 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Olpha As
Company Detail Path
/organization/olainfarm-predstavitelstvo
Company Information
Pharmaceutical Company Name
OLAINFARM, PREDSTAVITELSTVO
Country Name
Russia
City Name
moscow,moscow,country_ru
Address
d. 5 of. 1, shosse Golovinskoe
Active Ingredients
LENALIDOMIDA
25 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 26, 2021
Approval ID
4a7ab6050bd13bbe
Type
Standard
Back to CIMA-AEMPS Approvals
